Navigation Links
FDA Approves Tradjenta™ (linagliptin) Tablets for the Treatment of Type 2 Diabetes
Date:5/2/2011

at we hope will be many new treatment options this alliance brings to the millions of Americans living with type 2 diabetes."

The overall clinical development program for TRADJENTA consists of 30 studies completed, underway or planned. TRADJENTA is currently under regulatory review in the EU and Japan.  

To learn more about Tradjenta™ (linagliptin) tablets and for full prescribing information visit: www.TRADJENTA.com or call Boehringer Ingelheim Pharmaceuticals, Inc. at 1-800-542-6257.

Please report any unexpected effects or product problems to the Boehringer Ingelheim Drug Information Unit by calling 1-800-542-6257 (option 4).

About Diabetes

Approximately 25.8 million Americans(1) and an estimated 220 million people worldwide(2) have type 1 and type 2 diabetes. Type 2 diabetes is the most common type, accounting for an estimated 95 percent of all diabetes cases.(1) Diabetes is a chronic disease that occurs when the body either does not properly produce, or use, the hormone insulin.(3)

What are TRADJENTA tablets?

TRADJENTA is a prescription medicine that is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

TRADJENTA is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).

It is not known if TRADJENTA is safe and effective when used with insulin.

Important Safety Information

Who should not take TRADJENTA?

Do not take TRADJENTA if you are allergic to linagliptin or any of the ingredients in TRADJENTA.  

Symptoms of a serious allergic reaction to TRADJENTA are rash, raised red patches on your skin (hives), swelling of your face, lips, and throat that may cause difficulty
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... CAMBRIDGE, Mass. , Sept. 19, 2014   ... of advanced cancer genome analysis and testing services, ... discovering and developing highly selective kinase inhibitors for ... genomic study of malignant mixed Mullerian tumors (MMMT), ... reproductive system, also known as carcinosarcoma. The new ...
(Date:9/19/2014)... -- PCI is pleased to announce it has acquired ... provider of Clinical Trial Services and Temperature Controlled ... in the United Kingdom ... in the UK/EU to support global investigational studies ... distribution capacity, as well as consultative services for ...
(Date:9/18/2014)... , Sept. 18, 2014  Low T ... committee meeting in Hyattsville, Maryland ... to assess the proper patient population for testosterone ... cardiovascular risk associated with TRT. Examining recent claims from ... found that "available epidemiological studies do not provide ...
Breaking Medicine Technology:First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2
... Mich., April 28, 2011 Perrigo Company (Nasdaq: ... declared a quarterly dividend of $0.07 per share, ... record on May 27, 2011. Perrigo ... develops, manufactures and distributes over-the-counter (OTC) and generic ...
... 2011 Q1 2011 Change on a reported basis ... A/H1N1 salesNet sales , euro 7,779m-1.5% , -5.2% ... -16.1% , -5.8%Business EPS(1)euro 1.66-10.8%-16.1%-6.0% In order to facilitate ... our business net income statement. Business net income(1) is ...
Cached Medicine Technology:sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 2sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 3sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 4sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 5sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 6sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 7sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 8sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 9sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 10sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 11sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 12sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 13sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 14sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 15sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 16sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 17sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 18sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 19sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 20sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 21sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 22sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 23sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 24sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 25sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 26sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 27sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 28sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 29sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 30sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 31sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011 32
(Date:9/21/2014)... (PRWEB) September 21, 2014 Faculty and staff ... a coed preschool in Owings Mills, Md., kicked off the ... Garmin Vivofit bands. GFS is the first independent school to ... calories burned and even sleep patterns— as part of a ... area running and walking specialty chain. The Vivofit bands are ...
(Date:9/20/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer and ... dresses . In addition, the company has launched a special ... promotion is to benefit all of its big fans. Worldwide ... now. , Along with beautiful party dresses, the company ... recently released its new sexy short prom outfits and purple ...
(Date:9/20/2014)... Las Vegas, NV (PRWEB) September 21, 2014 ... and method created by fitness expert Craig Ballantyne that is ... boost their metabolism and blast away stubborn body fat using ... the attention of Shane Michaels, prompting an investigative review. ... equation isn’t always calories in vs. calories out for all ...
(Date:9/20/2014)... Increases in household, construction and commercial ... volumes. However, government regulations and higher landfill disposal ... to IBISWorld industry analyst Alen Allday, “over the ... reducing the volume of waste generated, and increasing ... a large proportion of waste generated by households ...
(Date:9/20/2014)... York, New York (PRWEB) September 20, 2014 ... filings continue to grow in federal court, Bernstein ... Food & Drug Administration (FDA) have voted overwhelmingly ... low testosterone in men be subjected to further ... According to a report published on September 18th ...
Breaking Medicine News(10 mins):Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3
... doubled their odds of success , , FRIDAY, ... can improve the chances that blacks who have kidney ... found. , "Research overwhelmingly indicates that African-Americans are less ... differences in socioeconomic and insurance status and patient preference," ...
... in New Financing- DailyMed(TM) Sales Expected to Increase More ... Resources, Inc. (NYSE Amex: KAD ), a ... the Arcadia HealthCare(SM) brand, today announced that it has ... outstanding debt, extending the maturity to April 2012, and ...
... March 27 Emageon Inc. (Nasdaq: EMAG ), ... networks, today announced that it and the other named defendants ... March 13, 2009 in connection with the proposed acquisition of ... entered into a memorandum of understanding with counsel for the ...
... of a single-engine turboprop plane in Montana killed 14 people ... crashes in recent months, including the February 12th crash of ... "Miracle on the Hudson" in which all 155 people survived, ... The horror of such an event is unimaginable, but author ...
... an estimated 1.5 million people in 2007. By 2013, the ... as many as 4 million Americans and that the cost ... $400 billion, making it the nation,s fastest-growing developmental disability. In ... the DePaul University College of Law will explore ...
... Illinois Medical District Commission , ... Chicago, IL (PRWEB) ... (IMD), the nation,s largest urban healthcare, educational, research and technology district, ... its Commission. Harte comes to the IMD with a strong background ...
Cached Medicine News:Health News:Networking May Aid Blacks Who Need Kidney Transplant 2Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 2Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 3Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 4Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 5Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 6Health News:Arcadia Completes New Financing; Previews Fourth Quarter Results 7Health News:Emageon Settles Shareholder Class Action Lawsuit 2Health News:Emageon Settles Shareholder Class Action Lawsuit 3Health News:Emageon Settles Shareholder Class Action Lawsuit 4Health News:What Is It Like to Survive a Plane Crash? A Survivor of One of the Worst Small Plane Crashes Tells Her Story 2Health News:Health Law Institute at DePaul University College of Law to Host Autism Symposium on World Autism Day, April 2 2Health News:Meghan Harte Appointed to the Illinois Medical District Commission 2
... The AngioJet Xpeedior+120 Rheolytic Thrombectomy catheter is ... performance. Powerful saline jets create a low ... a vacuum effect. Thrombus is drawn into ... the jets, and removed from the body.,AngioJet ...
... CARTO XP Electroanatomical Mapping System combines the ... the operating ease of Windows* software. ... adding powerful new tools that enhance your ... takes you into the future of EP. ...
... generators are meeting the clinical needs ... and anesthesiologists. And, they are of ... from Medtronic.,Effective pacing with the adjustment ... for quick battery changes. Both ...
... Medtronic's temporary pulse generators are ... surgeons, nurses, cardiologists, electrophysiologists and anesthesiologists. ... and durability you expect from Medtronic.,Effective ... Reverse battery polarity for quick ...
Medicine Products: